-
Axogen Announces Chief Financial Officer Transition
08 May 2025 11:00 GMT
… specializing in peripheral vascular and regenerative medicine products and held management roles … transform patients' lives.” About Axogen Axogen (AXGN) is the leading Company … nerve regeneration and repair. Axogen employees are passionate about helping …
-
AxoGen: Q1 Earnings Snapshot
08 May 2025 11:55 GMT
… (AP) — ALACHUA, Fla. (AP) — AxoGen Inc. (AXGN) on Thursday reported … (AP) — ALACHUA, Fla. (AP) — AxoGen Inc. (AXGN) on Thursday reported … cent per share.
The regenerative medicine company posted revenue of … $48.3 million.
AxoGen shares have fallen 0. …
-
Global Amniotic Membrane Market Poised for Extraordinary Growth at a CAGR of ~7% by 2032 | DelveInsight
30 Jul 2025 17:00 GMT
… Biosciences, Sanara MedTech Inc., Axogen Corporation, Dynamic Medical Services … by increasing investments in regenerative medicine, expanding clinical research demonstrating … Biosciences, Sanara MedTech Inc., Axogen Corporation, Dynamic Medical Services …
-
Axogen Announces Appointment of Jesse Bishop as Vice President of Regulatory Affairs and Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
03 Feb 2025 13:00 GMT
… such as Alliance for Regenerative Medicine (ARM), American Association … Officer, and Director, Axogen. "His extensive experience … next two years. About Axogen Axogen (AXGN) is the … regeneration and repair. Axogen employees are passionate about …
-
AxoGen: Q3 Earnings Snapshot
07 Nov 2024 13:14 GMT
… AP) — ALACHUA, Fla. (AP) — AxoGen Inc. (AXGN) on Thursday reported … AP) — ALACHUA, Fla. (AP) — AxoGen Inc. (AXGN) on Thursday reported … per-share basis.
The regenerative medicine company posted revenue of … expected $47 million.
AxoGen expects full-year revenue …
-
Axogen: Pioneering Nerve Repair With Innovative Off-the-Shelf Tissue Solutions
16 Oct 2024 15:19 GMT
… explore what makes Axogen unique within the Regenerative Medicine Subsector and dive … into its recent performance.
Axogen pioneers … , and upper extremity compression.
Axogen designs its leading product, Avance …
-
Axogen Completes Submission of Biologics License Application to U.S. Food and Drug Administration for Avance Nerve Graft®
06 Sep 2024 11:00 GMT
… Avance Nerve Graft previously received Regenerative Medicine Advanced Therapy (RMAT) designation from … September of next year. About Axogen Axogen (AXGN) is the leading company … nerve regeneration and repair. Axogen employees are passionate about helping …
-
AxoGen Q2 Earnings and Revenues Beat Estimates
08 Aug 2024 16:22 GMT
… it was expected that this regenerative medicine company would post a loss … EPS estimates four times.
AxoGen, which belongs to the … on the earnings call.
AxoGen shares have added about 16% … the estimate revisions trend for AxoGen: mixed. While the magnitude …
-
AxoGen: Q2 Earnings Snapshot
08 Aug 2024 14:01 GMT
… (AP) — ALACHUA, Fla. (AP) — AxoGen Inc. (AXGN) on Thursday reported … cents per share.
The regenerative medicine company posted revenue of … expected $43.3 million.
AxoGen expects full-year revenue … million to $186 million.
AxoGen shares have climbed 16% since …
-
Axogen Inc. Initiates Rolling Submission of Biologics License Application to U.S. Food and Drug Administration (FDA) for Avance Nerve Graft®
16 May 2024 11:00 GMT
… to streamline the development of regenerative medicine therapies intended for the treatment … approval around mid-2025. About Axogen
Axogen (AXGN) is the leading Company … peripheral nerve regeneration and repair. Axogen employees are passionate about helping …
About
© 1995-2025